This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2019 Oct 1;30(10):1673.

doi: 10.1093/annonc/mdz171.

OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer

T Y Seiwert, C C Foster, E A Blair, T G Karrison, N Agrawal, J M Melotek, L Portugal, R J Brisson, A Dekker, S Kochanny, Z Gooi, M W Lingen, V M Villaflor, D T Ginat, D J Haraf, E E Vokes

PMID: 31168601
DOI: 10.1093/annonc/mdz171

Free article

Published Erratum

OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer

T Y Seiwert et al. Ann Oncol. 2019.

Free article

. 2019 Oct 1;30(10):1673.

doi: 10.1093/annonc/mdz171.

Authors

T Y Seiwert, C C Foster, E A Blair, T G Karrison, N Agrawal, J M Melotek, L Portugal, R J Brisson, A Dekker, S Kochanny, Z Gooi, M W Lingen, V M Villaflor, D T Ginat, D J Haraf, E E Vokes

PMID: 31168601
DOI: 10.1093/annonc/mdz171

No abstract available

PubMed Disclaimer

Erratum for

OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer.
Seiwert TY, Foster CC, Blair EA, Karrison TG, Agrawal N, Melotek JM, Portugal L, Brisson RJ, Dekker A, Kochanny S, Gooi Z, Lingen MW, Villaflor VM, Ginat DT, Haraf DJ, Vokes EE. Seiwert TY, et al. Ann Oncol. 2019 Feb 1;30(2):297-302. doi: 10.1093/annonc/mdy522. Ann Oncol. 2019. PMID: 30481287 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.